Breast Cancer Tissue Array of 96 Tissue Samples
      Home >> Welcome to Pantomics                                                                          Price List Download

Dedicated facility

 Catalog# BRC961 - Human breast cancer tissue array

    
Lot# Cores Size Cut Format QA/QC Price
1Slide		 Price
Pack5
BRC96101 96 1.5mm 4um 8X12 H&E, IHC anti-Vimentin/Cytokeratin $100 $400
Order: sales@pantomics.com or call  1-415-863-2380, Form: Word or PDF; PDF data
 
   
Recommended applications: For Research use only. RNA or protein breast cancer/non-tumor tissue profiling using IHC or ISH; Antibody characterization.

Description: Breast cancer tissue array, 96 cores including 36 cases (purple/blue) of breast cancers and 12 cases of normal, reactive and  benign tumor tissues of the breast (pink) in duplicates. All the tissues were from surgical resection. They were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They all have a guaranteed six months' shelf-life at 4C from the date of shipment. Each slide has >95% tissue core retention.
   
   

Array
position

Age

Sex

Histology

Grade

Stage (TNM)

AR

ER

PR

HER2

A1,B1

41

F

Normal

 

 

-

+, 10%

++, 5%

+

A2,B2

58

F

Normal

 

 

-

++, 5%

++, 5%

-

A3,B3

24

F

Normal

 

 

-

+, 2%

+++, 5%

-

A4,B4

43

F

Normal

 

 

-

+, 1%

+++, 5%

-

A5,B5

34

F

Blunt duct adenosis

 

 

-

+, 2%

++, 2%

-

A6,B6

18

F

Blunt duct adenosis

 

 

-

-

-

-

A7,B7

38

F

Blunt duct adenosis

 

 

-

++, 2%

++, 5%

-

A8,B8

41

F

Fibrocystic changes

 

 

+, 5%

+, 5%

+++, 80%

-

A9,B9

41

F

Fibrocystic changes

 

 

++, 20%

+, 5%

+++, 60%

+~++

A10,B10

39

F

Fibroadenoma

 

 

-

-

++, 2%

+

A11,B11

40

F

Fibroadenoma

 

 

++, 10%

++, 15%

+++, 60%

+

A12,B12

34

F

Fibroadenoma

 

 

+, 10%

+++, 50%

+++, 80%

+-

C1,D1

38

F

Phyllodes sarcoma

 

 

 

 

 

 

C2,D2

52

F

Ductal carcinoma in situ

I

TisN0M0

-

+++, 90%

+, 1%

++

C3,D3

28

F

Ductal carcinoma in situ

I

TisN0M0

-

-

-

+++

C4,D4

41

F

Ductal carcinoma in situ

I

TisN0M0

++, 15%

+, 30%

+++, 80%

+

C5,D5

58

F

Invasive ductal carcinoma

I~II

T2N0M0

-

-

-

+++

C6,D6

53

F

Invasive ductal carcinoma

II

T2N0M0

-

-

-

+

C7,D7

55

F

Invasive ductal carcinoma

II

T2N0M0

++, 15%

+++, 80%

-

++

C8,D8

44

F

Invasive ductal carcinoma

II~III

T2N0M0

-

-

-

-

C9,D9

34

F

Invasive ductal carcinoma

II~III

T2N0M0

+, 5%

+, 50%

+, 5%

-

C10,D10

72

F

Invasive ductal carcinoma

III

T2N0M0

+, 10%

-

-

+++

C11,D11

41

F

Invasive ductal carcinoma

II~III

T2N1M0

-

+, 20%

-

+++

C12,D12

18

F

Invasive ductal carcinoma

III

T2N0M0

-

-

-

+

E1,F1

31

F

Invasive ductal carcinoma

III

T2N0M0

-

-

-

+++

E2,F2

54

F

Invasive ductal carcinoma

II~III

T2N0M0

-

-

-

+++

E3,F3

44

F

Invasive ductal carcinoma

II

T2N0M0

-

+, 10%

++, 5%

+-

E4,F4

58

F

Invasive ductal carcinoma

III

T2N0M0

-

+, 50%

-

++

E5,F5

75

F

Invasive ductal carcinoma

III

T3N0M0

-

+~+++, 80%

++~+++, 30%

-

E6,F6

43

F

Invasive ductal carcinoma

II~III

T2N0M0

-

-

-

+-

E7,F7

43

F

Invasive ductal carcinoma

III

T3N0M0

-

-

-

-

E8,F8

37

F

Invasive ductal carcinoma

III

T2N0M0

-

-

+~++, 20%

+++

E9,F9

50

F

Invasive ductal carcinoma

II~III

T2N0M0

-

-

-

-

E10,F10

46

F

Invasive ductal carcinoma

II~III

T2N0M0

-

+, 5%

-

+

E11,F11

40

F

Invasive ductal carcinoma

II~III

T2N0M0

-

+, 30%

+~++, 20%

-

E12,F12

60

F

Invasive ductal carcinoma

II

T2N0M0

-

-

-

+++

G1,H1

35

F

Invasive ductal carcinoma

III

T2N0M0

++, 60%

++, 80%

++, 10%

+++

G2,H2

37

F

Invasive ductal carcinoma

II~III

T2N0M0

-

+, 50%

-

-

G3,H3

58

F

Invasive ductal carcinoma

II~III

T2N0M0

-

++, 80%

+, 15%

+

G4,H4

49

F

Invasive ductal carcinoma

III

T2N0M0

-

-

-

+++

G5,H5

52

F

Invasive ductal carcinoma

III

T1N0M0

-

+, 10%

++~+++, 30%